Search research articles
Contact Us
Filters
Showing results (11-20 of 26) with videos related to
Page
of 3
Sort By:
Neuropharmacology
|
July 18, 2018
The α6 subunit-containing GABA<sub>A</sub> receptor: A novel drug target for inhibition of trigeminal activation
Pi-Chuan Fan, Tzu-Hsuan Lai, Chia Chun Hor, et al.
Molecular Pharmaceutics
|
February 19, 2020
The Effects of pH on the Structure and Bioavailability of Imidazobenzodiazepine-3-Carboxylate MIDD0301
M S Rashid Roni, Guanguan Li, Brandon N Mikulsky, et al.
European Journal of Pain (London, England)
|
January 12, 2019
Trigeminal neuropathic pain development and maintenance in rats are suppressed by a positive modulator of α6 GABA<sub>A</sub> receptors
Dina Vasović, Branka Divović, Marco Treven, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie
|
April 28, 2022
Targeting α6GABA<sub>A</sub> receptors as a novel therapy for schizophrenia: A proof-of-concept preclinical study using various animal models
Ming Tatt Lee, Akihiro Mouri, Hisayoshi Kubota, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences
|
August 6, 2023
Freeze-dried nanocrystal dispersion of novel deuterated pyrazoloquinolinone ligand (DK-I-56-1): Process parameters and lyoprotectant selection through the stability study
Jelena R Mitrović, Maja Bjelošević Žiberna, Aleksandar Vukadinović, et al.
Current Drug Metabolism
|
December 3, 2021
Identification and Quantification of MIDD0301 Metabolites
M S Rashid Roni, Nicolas M Zahn, Brandon N Mikulsky, et al.
ACS Pharmacology & Translational Science
|
December 21, 2020
Nebulized MIDD0301 Reduces Airway Hyperresponsiveness in Moderate and Severe Murine Asthma Models
Nicolas M Zahn, Brandon N Mikulsky, M S Rashid Roni, et al.
Pharmaceutics
|
August 28, 2021
Overcoming the Low Oral Bioavailability of Deuterated Pyrazoloquinolinone Ligand DK-I-60-3 by Nanonization: A Knowledge-Based Approach
Jelena R Mitrović, Branka Divović-Matović, Daniel E Knutson, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences
|
June 23, 2020
Nanocrystal dispersion of DK-I-56-1, a poorly soluble pyrazoloquinolinone positive modulator of α6 GABAA receptors: Formulation approach toward improved in vivo performance
Jelena R Mitrović, Branka Divović, Daniel E Knutson, et al.
Pharmacology, Biochemistry, and Behavior
|
January 18, 2022
The imidazodiazepine, KRM-II-81: An example of a newly emerging generation of GABAkines for neurological and psychiatric disorders
Jeffrey M Witkin, Arnold Lippa, Jodi L Smith, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 26) with videos related to
Sort By:
Page
of 3
Neuropharmacology
|
July 18, 2018
The α6 subunit-containing GABA<sub>A</sub> receptor: A novel drug target for inhibition of trigeminal activation
Pi-Chuan Fan, Tzu-Hsuan Lai, Chia Chun Hor, et al.
Molecular Pharmaceutics
|
February 19, 2020
The Effects of pH on the Structure and Bioavailability of Imidazobenzodiazepine-3-Carboxylate MIDD0301
M S Rashid Roni, Guanguan Li, Brandon N Mikulsky, et al.
European Journal of Pain (London, England)
|
January 12, 2019
Trigeminal neuropathic pain development and maintenance in rats are suppressed by a positive modulator of α6 GABA<sub>A</sub> receptors
Dina Vasović, Branka Divović, Marco Treven, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie
|
April 28, 2022
Targeting α6GABA<sub>A</sub> receptors as a novel therapy for schizophrenia: A proof-of-concept preclinical study using various animal models
Ming Tatt Lee, Akihiro Mouri, Hisayoshi Kubota, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences
|
August 6, 2023
Freeze-dried nanocrystal dispersion of novel deuterated pyrazoloquinolinone ligand (DK-I-56-1): Process parameters and lyoprotectant selection through the stability study
Jelena R Mitrović, Maja Bjelošević Žiberna, Aleksandar Vukadinović, et al.
Current Drug Metabolism
|
December 3, 2021
Identification and Quantification of MIDD0301 Metabolites
M S Rashid Roni, Nicolas M Zahn, Brandon N Mikulsky, et al.
ACS Pharmacology & Translational Science
|
December 21, 2020
Nebulized MIDD0301 Reduces Airway Hyperresponsiveness in Moderate and Severe Murine Asthma Models
Nicolas M Zahn, Brandon N Mikulsky, M S Rashid Roni, et al.
Pharmaceutics
|
August 28, 2021
Overcoming the Low Oral Bioavailability of Deuterated Pyrazoloquinolinone Ligand DK-I-60-3 by Nanonization: A Knowledge-Based Approach
Jelena R Mitrović, Branka Divović-Matović, Daniel E Knutson, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences
|
June 23, 2020
Nanocrystal dispersion of DK-I-56-1, a poorly soluble pyrazoloquinolinone positive modulator of α6 GABAA receptors: Formulation approach toward improved in vivo performance
Jelena R Mitrović, Branka Divović, Daniel E Knutson, et al.
Pharmacology, Biochemistry, and Behavior
|
January 18, 2022
The imidazodiazepine, KRM-II-81: An example of a newly emerging generation of GABAkines for neurological and psychiatric disorders
Jeffrey M Witkin, Arnold Lippa, Jodi L Smith, et al.
Page
of 3